1. Home
  2. G vs HALO Comparison

G vs HALO Comparison

Compare G & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genpact Limited

G

Genpact Limited

HOLD

Current Price

$45.69

Market Cap

7.2B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$71.18

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
G
HALO
Founded
1997
1998
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.5B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
G
HALO
Price
$45.69
$71.18
Analyst Decision
Buy
Buy
Analyst Count
7
12
Target Price
$51.00
$76.42
AVG Volume (30 Days)
1.2M
1.8M
Earning Date
02-05-2026
02-17-2026
Dividend Yield
1.48%
N/A
EPS Growth
N/A
56.68
EPS
3.10
4.74
Revenue
$5,009,342,000.00
$1,242,852,000.00
Revenue This Year
$8.47
$34.54
Revenue Next Year
$6.90
$26.28
P/E Ratio
$14.81
$15.04
Revenue Growth
7.39
31.19
52 Week Low
$37.49
$47.50
52 Week High
$56.76
$79.50

Technical Indicators

Market Signals
Indicator
G
HALO
Relative Strength Index (RSI) 44.18 55.42
Support Level $46.35 $70.75
Resistance Level $47.91 $74.08
Average True Range (ATR) 0.98 2.07
MACD -0.30 0.10
Stochastic Oscillator 15.20 51.05

Price Performance

Historical Comparison
G
HALO

About G Genpact Limited

Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: